Show simple item record

Authordc.contributor.authorQuintanilla González, María Elena 
Authordc.contributor.authorEzquer, Fernando 
Authordc.contributor.authorMorales Retamales, Paola 
Authordc.contributor.authorEzquer, Marcelo 
Authordc.contributor.authorOlivares, Belén 
Authordc.contributor.authorSantapau, Daniela 
Authordc.contributor.authorHerrera-Marschitz Muller, Mario 
Authordc.contributor.authorIsrael Jacard, Yedy 
Admission datedc.date.accessioned2020-11-02T20:07:46Z
Available datedc.date.available2020-11-02T20:07:46Z
Publication datedc.date.issued2020
Cita de ítemdc.identifier.citationFrontiers in Behavioral Neuroscience July 2020 | Volume 14 | Article 122es_ES
Identifierdc.identifier.other10.3389/fnbeh.2020.00122
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/177500
Abstractdc.description.abstractChronic ethanol intake results in brain oxidative stress and neuroinflammation, which have been postulated to perpetuate alcohol intake and to induce alcohol relapse. The present study assessed the mechanisms involved in the inhibition of: (i) oxidative stress; (ii) neuroinflammation; and (iii) ethanol intake that follow the administration of the antioxidant N-acetylcysteine (NAC) and the anti-inflammatory acetylsalicylic acid (ASA) to animals that had consumed ethanol chronically. At doses used clinically, NAC [40 mg/kg per day orally (p.o.)] and ASA (15 mg/kg per day p.o.) significantly inhibited chronic alcohol intake and relapse intake in alcohol-preferring rats. The coadministration of both drugs reduced ethanol intake by 65% to 70%. N-acetylcysteine administration: (a) induced the Nrf2-ARE system, lowering the hippocampal oxidative stress assessed as the ratio of oxidized glutathione (GSSG)/reduced glutathione (GSH); (b) reduced the neuroinflammation assessed by astrocyte and microglial activation by immunofluorescence; and (c) inhibited chronic and relapse ethanol intake. These effects were blocked by sulfasalazine, an inhibitor of the xCT transporter, which incorporates cystine (precursor of GSH) and extrudes extracellular glutamate, an agonist of the inhibitory mGlu2/3 receptor, which lowers the synaptic glutamatergic tone. The inhibitor of mGlu2/3 receptor (LY341495) blocked the NAC-induced inhibition of both relapse ethanol intake and neuroinflammation without affecting the GSSG/GSH ratio. Unlike N-acetylcysteine, ASA inhibited chronic alcohol intake and relapsevialipoxin A4, a strong anti-inflammatory metabolite of arachidonic acid generated following the ASA acetylation of cyclooxygenases. Accordingly, the lipoxin A4 receptor inhibitor, WRW4, blocked the ASA-induced reduction of ethanol intake. Overall,viadifferent mechanisms, NAC and ASA administered in clinically relevant doses combine their effects inhibiting ethanol intake.es_ES
Patrocinadordc.description.sponsorshipComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDECYT 1180042 1190562 1200287es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherFrontiers Mediaes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceFrontiers in Behavioral Neurosciencees_ES
Keywordsdc.subjectN-acetylcysteinees_ES
Keywordsdc.subjectAspirines_ES
Keywordsdc.subjectEthanoles_ES
Keywordsdc.subjectRelapsees_ES
Keywordsdc.subjectRatses_ES
Títulodc.titleN-Acetylcysteine and Acetylsalicylic Acid Inhibit Alcohol Consumption by Different Mechanisms: Combined Protectiones_ES
Document typedc.typeArtículo de revistaes_ES
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogueruchile.catalogadorcrbes_ES
Indexationuchile.indexArtículo de publicación ISI
Indexationuchile.indexArtículo de publicación SCOPUS


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile